Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE)

 
ZYNE Technical Analysis
5
As on 25th Jan 2022 ZYNE Share Price closed @ 2.52 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.40 & Strong Sell for SHORT-TERM with Stoploss of 3.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ZYNE Share Price

Open 2.43 Change Price %
High 2.52 1 Day 0.02 0.80
Low 2.37 1 Week -0.03 -1.18
Close 2.52 1 Month -0.80 -24.10
Volume 1526412 1 Year -0.77 -23.40
52 Week High 8.76 | 52 Week Low 2.37
 
NASDAQ USA Most Active Stocks
XELA 0.55 34.15%
AAPL 159.78 -1.14%
AMD 111.13 -4.63%
SOFI 12.76 -4.06%
NVDA 223.24 -4.48%
MSFT 288.49 -2.66%
SNDL 0.48 4.35%
BBIG 3.01 2.73%
INTC 51.00 -1.81%
PIXY 1.55 -9.88%
 
NASDAQ USA Top Gainers Stocks
CETXW 0.02 100.00%
ZJZZT 37.50 79.86%
AKICW 0.77 60.42%
ZWZZT 22.00 46.67%
SRRA 22.68 46.23%
DBGIW 0.49 40.00%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
DSKEW 0.01 -66.67%
IKNX 19.52 -42.42%
PAVMW 0.03 -40.00%
OTLKW 0.03 -40.00%
XBIOW 1.30 -35.00%
ROVRW 1.30 -34.34%
STMP 0.02 -33.33%
STMP 0.02 -33.33%
IMRNW 0.20 -33.33%
 
 
ZYNE
Daily Charts		 ZYNE
Intraday Charts		 Whats New @
Bazaartrend		 ZYNE
Free Analysis
 
ZYNE Important Levels Intraday
RESISTANCE2.81
RESISTANCE2.72
RESISTANCE2.66
RESISTANCE2.60
SUPPORT2.44
SUPPORT2.38
SUPPORT2.32
SUPPORT2.23
 
ZYNE Target for Month January
Share
4th UP TARGET5.43
3rd UP TARGET4.5
2nd UP TARGET3.92
1st UP TARGET3.34
1st DOWN TARGET1.7
2nd DOWN TARGET1.12
3rd DOWN TARGET0.54
4th DOWN TARGET-0.39
 
ZYNE Weekly Target
4th UP TARGET4.56
3rd UP TARGET3.91
2nd UP TARGET3.50
1st UP TARGET3.10
1st DOWN TARGET1.94
2nd DOWN TARGET1.54
3rd DOWN TARGET1.13
4th DOWN TARGET0.48
 
ZYNE Target for Year 2022
4th UP TARGET15.6
3rd UP TARGET11.41
2nd UP TARGET8.81
1st UP TARGET6.22
1st DOWN TARGET-1.18
2nd DOWN TARGET-3.77
3rd DOWN TARGET-6.37
4th DOWN TARGET-10.56
 
 
ZYNE Other Details
Segment EQ
Market Capital 155518160.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
ZYNE Address
ZYNE
 
ZYNE Latest News
 
Your Comments and Response on Zynerba Pharmaceuticals Inc
 
ZYNE Business Profile
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania. Address: 80 West Lancaster Avenue, Devon, PA, United States, 19333
 
© 2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service